Allakos Inc
NASDAQ:ALLK 11:39:39 AM EDT
Allakos Inc. Stock, NASDAQ:ALLK
75 SHOREWAY ROAD, SUITE A, SAN CARLOS, CA 94070
United States of America
Phone: 650-597-5002
Number of Employees: 62
Description
Allakos Inc. operates as a clinical stage biopharmaceutical company. The company is developing antolimab (AK002) for the treatment of eosinophilic gastritis and eosinophilic gastroenteritis, chronic urticaria, indolent systemic mastocytosis, and severe allergic conjunctivitis. Allakos Inc. was founded in 2012 and is headquartered in Redwood City, California.